Human nuclear transcription factor gene CREM: Genomic organization, mutation screening, and association analysis in panic disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 117 B, Issue 1, 2003, Pages 70-78

  Domschke, K ^a   Kuhlenbaumer G ^a   Schirmacher, A ^a   Lorenzi, C ^f   Armengol, L ^g   DiBella, D ^f   Gratacos, M ^g   Garritsen, H S ^a   Nothen M M ^b,e   Franke, P ^b   Sand, P ^c   Fritze, J ^d   Perez, G ^g   Maier, W ^b   Sibrowski, W ^a   Estivill, X ^g   Bellodi, L ^f   Ringelstein, E B ^a   Arolt, V ^a   Martin Santos, R ^g   Catalano, M ^f   Stogbauer F ^a   Deckert, J ^a   more..

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g HOSPITAL DEL MAR   (Spain)

Author keywords

Agoraphobia; CREM; Panic disorder; Polymorphism; Promoter; Trinucleotide repeat

Indexed keywords

GENE PRODUCT; TRANSCRIPTION FACTOR;

AGORAPHOBIA; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; GENE MUTATION; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HERITABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PANIC; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0037904330     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10018     Document Type: Article

References (42)

1. Abelson JL, Curtis GC. 1996. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 53:323-331.
2. Belkhir K, Borsa P, Goudet J, Chikhi L, Bonhomme F. 1996. Genetix v3.0 logiciel sous Windows TM pour la genetique des populations. Laboratoire Genome et Populations, CNRS UPR 9060, Universite de Montpellier 2.
3. Birnstiel ML, Busslinger M, Strub K. 1985. Transcription termination and 3' processing: The end is in site! Cell 41:349-359.
4. Breathnach R, Benoist C, O'Hare K, Gannon F, Chambon P. 1978. Ovalbumin gene: Evidence for a leader sequence in mRNA and DNA sequences at the exon/intron boundaries. Proc Natl Acad Sci USA 75:4853-4857.
5. Bucan M, Abel T. 2002. The mouse: Genetics meets behaviour. Nat Rev Genet 3:114-123.
6. CDCP, USA, WHO. 1997. Epi-Info 6.04b - A word processing, database, and statistics program for public health.
7. Crowe RR, Goedken R, Samuelson S, Wilson R, Nelson J, Noyes R. 2001. Genomewide survey of panic disorder. Am J Med Genet 105:105-109.
8. Daniel PB, Rohrbach L, Habener JF. 2000. Novel cyclic adenosine 3′,5′′-monophosphate (cAMP) response element modulator theta isoforms expressed by two newly identified cAMP-responsive promoters active in the testis. Endocrinology 141:3923-3930.
9. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M, Maier W, Beckmann H, Propping P. 1998. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3:81-85.
10. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, DiBella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
11. Delmas V, Laoide BM, Masquilier D, de Groot RP, Foulkes NS, Sassone-Corsi P. 1992. Alternative usage ofinitiation codons in mRNA encoding the cAMP-responsive-element modulator generates regulators with opposite functions. Proc Natl Acad Sci USA 89:4226-4230.
12. Foulkes NS, Borrelli E, Sassone-Corsi P. 1991. CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64:739-749.
13. Fujimoto T, Fujisawa J, Yoshida M. 1994. Novel isoforms of human cyclic AMP-responsive element modulator (hCREM) mRNA. J Biochem (Tokyo) 115:298-303.
14. Gelernter J, Bonvicini K, Page G, Woods SW, Goddard AW, Kruger S, Pauls DL, Goodson S. 2001. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet 105:548-557.
15. Hattori E, Ebihara M, Yamada K, Ohba H, Shibuya H, Yoshikawa T. 2001. Identification of a compound short tandem repeat stretch in the 5′-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia. Mol Psychiatry 6:465-470.
16. Hayashi K, Yandell DW. 1993. How sensitive is PCR-SSCP? Hum Mutat 2:338-346.
17. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568-1578.
18. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1993. Panic disorder in women: A population-based twin study. Psychol Med 23:397-406.
19. Knowles JA, Fyer AJ, Vieland VJ, Weissman MM, Hodge SE, Heiman GA, Haghighi F, de Jesus GM, Rassnick H, Preud'homme-Rivelli X, Austin T, Cunjak J, Mick S, Fine LD, Woodley KA, Das K, Maier W, Adams PB, Freimer NB, Klein DF, Gilliam TC. 1998. Results of a genome-wide genetic screen for panic disorder. Am J Med Genet 81:139-147.
20. Kukita Y, Tahira T, Sommer SS, Hayashi K. 1997. SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 10:400-407.
21. Lamas M, Molina C, Foulkes NS, Jansen E, Sassone-Corsi P. 1997. Ectopic ICER expression in pituitary corticotroph AtT20 cells: Effects on morphology, cell cycle, and hormonal production. Mol Endocrinol 11:1425-1434.
22. Lander ES, Schork NJ. 1994. Genetic dissection of complex traits. Science 265:2037-2048.
23. Laoide BM, Foulkes NS, Schlotter F, Sassone-Corsi P. 1993. The functional versatility of CREM is determined by its modular structure. EMBO J 12:1179-1191.
24. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association ofanxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
25. Maier W, Lichtermann D, Minges J, Oehrlein A, Franke P. 1993. A controlled family study in panic disorder. J Psychiatr Res 27:79-87.
26. Maldonado R, Smadja C, Mazzucchelli C, Sassone-Corsi P, Mazzucchelli C. 1999. Altered emotional and locomotor responses in mice deficient in the transcription factor CREM. Proc Natl Acad Sci USA 96:14094-14099.
27. Mannuzza S, Fyer AJ, Klein DF, Endicott J. 1986. Schedule for affective disorders and schizophrenia-Lifetime version modified for the study ofanxiety disorders (SADS-LA): Rationale and conceptual development. J Psychiatr Res 20:317-325.
28. Masquilier D, Foulkes NS, Mattei MG, Sassone-Corsi P. 1993. Human CREM gene: Evolutionary conservation, chromosomal localization, and inducibility of the transcript. Cell Growth Differ 4:931-937.
29. Mazzucchelli C, Sassone-Corsi P. 1999. The inducible cyclic adenosine monophosphate early repressor (ICER) in the pituitary intermediate lobe: Role in the stress response. Mol Cell Endocrinol 155:101-113.
30. Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P. 1993. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor. Cell 75:875-886.
31. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770.
32. Robins L, Helzer J, Cottler L. 1988. Diagnostic interview schedule, version III, revised (DIS-R). St. Louis, MO: Washington University Press.
33. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA, Sartorius N, Towle LH. 1988. The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069-1077.
34. Rozen S, Skaletsky H. 2000. Primer 3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386.
35. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, Windemuth C, Neidt H, Grassle M, Papassotiropoulos A, Heun R, Nothen MM, Maier W, Lesch KP, Rietschel M. 2000. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96:801-803.
36. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
37. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. 1993. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16:325-332.
38. Spitzer R. 1985. Structured clinical interview for DSM-III-R. New York, NY: New York Psychiatric Institute.
39. Stehle JH, Foulkes NS, Molina CA, Simonneaux V, Pevet P, Sassone-Corsi P. 1993. Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland. Nature 365:314-320.
40. Vieland VJ, Goodman DW, Chapman T, Fyer AJ. 1996. New segregation analysis of panic disorder. Am J Med Genet 67:147-153.
41. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK. 1997. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305-309.
42. Wittchen HU, Reed V, Kessler RC. 1998. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch Gen Psychiatry 55:1017-1024.